Within the Acne Treatment Market , topical treatments hold the largest share at 63%, reflecting their widespread use for mild to moderate acne. These products, which include creams, gels, and lotions, are favored for their ease of application, direct action on affected areas, and availability over the counter. Key active ingredients in topical treatments include benzoyl peroxide, which kills acne-causing bacteria; retinoids, which unclog pores and promote cell turnover; and salicylic acid, which exfoliates the skin. The market has seen significant innovation in this segment, with the development of combination products that pair multiple active ingredients for enhanced efficacy. In Q2 2024, Galderma received FDA approval for Twyneo Cream, a topical treatment combining tretinoin and benzoyl peroxide.
While topical treatments dominate, oral treatments are the fastest-growing segment, driven by their effectiveness in treating moderate to severe acne. Oral treatments include antibiotics, which target bacterial infection; hormonal therapies such as contraceptives and anti-androgens, which address hormonal imbalances; and isotretinoin, a powerful retinoid used for severe, treatment-resistant acne. The growing prevalence of severe acne cases and the increasing number of dermatology consultations are driving the adoption of oral treatments. The development of new oral formulations is also contributing to segment growth. In Q1 2025, Bausch Health received FDA approval for a new oral acne therapy.
Systemic treatments, which include antibiotics and intralesional steroid injections, represent another important category. These are typically used for severe or inflammatory acne that does not respond to topical or oral therapies. The systemic segment was valued at USD 3.0 billion in 2024.
The segmentation by acne severity also highlights market dynamics. The moderate acne segment holds the largest share at 49%, driven by the high prevalence of moderate acne cases among adolescents and young adults. This demographic requires effective solutions that can manage breakouts and prevent progression to more severe forms. The high severity segment is the fastest-growing, driven by increasing numbers of individuals seeking professional treatments and advanced therapies for severe acne conditions. This segment demands more intense therapies, including systemic medications and advanced treatments like laser therapies or chemical peels. As the market evolves, the availability of targeted therapies for different severity levels will continue to expand.
